Morphea in two patients after being infected to and being vaccinated against SARS‐CoV‐2 infection

Abstract

Although the presence of morphea following COVID-19 has been rarely reported, the development of its generalized form following COVID-19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID-19 vaccination and another similar case following SARS-Cov-2 infection. Other etiologic factors were also dealt with.

New‐onset pemphigus foliaceus following SARS‐CoV‐2 infection and unmasking multiple sclerosis: A case report

“…[9][10][11][12] Reviewing the literature had led us to merely one case of SARS-CoV-2-related PF, which appeared after receiving Bamlanivimab. 13 However, our case was a newonset PF without a history of drug consumption.…”

“…The SARS‐CoV‐2 infection has given rise to many cases of dermatoses, either new‐onset or exacerbation, with pemphigus family being one of them 9–12 . Reviewing the literature had led us to merely one case of SARS‐CoV‐2‐related PF, which appeared after receiving Bamlanivimab 13 . However, our case was a new‐onset PF without a history of drug consumption.…”

“…2,3 Moreover, skin lesions have been the initial manifestation of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or the consequence of the recent infection and its treatment. 4,5 Up to the present time, several cases of pemphigus vulgaris (PV) and bullous pemphigoid have been reported following SARS-CoV-2 infection 6,7 ; however, to our knowledge, our patient has been the first cases of pemphigus foliaceus (PF) and multiple sclerosis (MS) arising after COVID infection.…”

“…The cutaneous involvement have been either new‐onset or exacerbation of the preexisting dermatosis 2,3 . Moreover, skin lesions have been the initial manifestation of infection with the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) or the consequence of the recent infection and its treatment 4,5 …”

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

“…136 Moreover, 40 cases of pemphigoids have been described. [137][138][139][140][141][142][143][144][145][146][147][148][149][150][151] Regarding other cutaneous diseases developed following COVID-19 vaccination, 9, 40, 55, 12 and 11 cases of morphea, [152][153][154][155][156][157] pityriasis rosea, [158][159][160][161][162][163][164][165][166][167][168][169][170][171][172][173][174][175][176][177] herpes zoster, [178][179][180][181][182][183][184]…”